五礦資源(01208.HK)附屬獲1.5億美元信貸融資
五礦資源(01208.HK)公布,其附屬公司MLB與中國工商銀行已簽訂貸款協議。根據貸款協議,MLB已獲授予為期三年的1.5億美元信貸融資,以用作一般資金需求。該貸款取代了貸款人於2019年8月至2022年8月期間向公司提供的1.75億美元的營運資金融資,將於期內可供提取,已償還金額可供再提取。
根據與借款人巴拿馬各分行簽訂之貸款協議,該貸款協議由三批組成,每批為5,000萬美元,以供提取。
根據相關條款,如中國五礦不再實益持有超過公司50%已發行股本;或中國五礦不再直接或間接有權,借款人可在向MLB發出不少於三天的通知,宣布貸款協議項下之所有未償還貸款即時到期及須予償還。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.